ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 975

IL-17A Induced Autophagy That the Proliferation of Rheumatoid Arthritis Fibroblast-like Synoviocytes through Down-Regulation of PI3K/AKT/mTOR Signaling Pathway

Sang-Hyon Kim1, Jihye Bang2, Ji-Min Kim1, Chang-Nam Son1, Jin-Nyeong Chae1 and Hye-Jin Jeong3, 1Division of Rheumatology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea, Daegu, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea, Republic of (South), 3Department of Rheumatology, Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autophagy, Fibroblasts, inflammatory cytokines and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster II: Mesenchymal Cells Do React - But How?

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Autophagy is generally thought of as a survival mechanism, although its deregulation has been linked to non-apoptotic cell death. Fibroblast-like synoviocytes (FLS) resistance to apoptosis is a major characteristic of rheumatoid arthritis (RA). We hypothesized that interleukin (IL)-17A might have an impact on autophagic flux and that modulation of autophagy might be involved in migration and proliferation of synovial fibroblasts in the patients with RA under inflammatory condition.

Methods: Synovial tissue was obtained from clinically involved knee joints of patients with RA or osteoarthritis (OA) patients. The autophagosome of FLS isolated from RA and OA patients displayed different morphological and physiological features by using transmission electron microscopy. The effects of IL-17 on the relationship between autophagy and cell migration were evaluated with co-treatment of autophagy inhibitor using bafilomycin A1 and transfection of si-Atg5.

Results: IL-17 induced autophagosome formation and autolysosome accumulation in RA FLS, suggesting that they were resistant to apoptosis. IL-17A increased autophagy of RA FLS by causing up-regulation of LC3II, Atg5 and Beclin1. Migration and proliferation of FLS stimulated by IL-17A was suppressed by bafilomycin A1 and si-Atg5 which knocked down of autophagy. And, autophagy inhibitor regulated signaling pathway which decreased IL-17A-induced expression of phosphorylation-Akt and increased mTOR signaling pathway.

Conclusion: Taken together, our findings demonstrated that IL-17A could induce activate autophagy, induce inflammatory response, and eventually lead to proliferation of synoviocytes. We suggest that autophagy can be one of the therapeutic target for the RA management.


Disclosure: S. H. Kim, None; J. Bang, None; J. M. Kim, None; C. N. Son, None; J. N. Chae, None; H. J. Jeong, None.

To cite this abstract in AMA style:

Kim SH, Bang J, Kim JM, Son CN, Chae JN, Jeong HJ. IL-17A Induced Autophagy That the Proliferation of Rheumatoid Arthritis Fibroblast-like Synoviocytes through Down-Regulation of PI3K/AKT/mTOR Signaling Pathway [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/il-17a-induced-autophagy-that-the-proliferation-of-rheumatoid-arthritis-fibroblast-like-synoviocytes-through-down-regulation-of-pi3kaktmtor-signaling-pathway/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-17a-induced-autophagy-that-the-proliferation-of-rheumatoid-arthritis-fibroblast-like-synoviocytes-through-down-regulation-of-pi3kaktmtor-signaling-pathway/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology